• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

十年本地化胰腺癌新辅助治疗优化经验——威斯康星医学院观点。

Ten-year experience in optimizing neoadjuvant therapy for localized pancreatic cancer-Medical college of Wisconsin perspective.

机构信息

Department of Surgery, LaBahn Pancreatic Cancer Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

出版信息

J Surg Oncol. 2021 May;123(6):1405-1413. doi: 10.1002/jso.26395.

DOI:10.1002/jso.26395
PMID:33831252
Abstract

Treatment of localized pancreatic cancer has also evolved to prioritize preoperative (neoadjuvant) multimodality therapy over a surgery-first approach. Given the complexities of pancreatic cancer staging and the challenge of delivering multiple treatment modalities (chemotherapy, radiation therapy, and surgery), an experienced and highly integrated multidisciplinary team is necessary to achieve the best outcomes. In this review, we will discuss our institutional experience with neoadjuvant therapy, guiding principles for treatment, and outline the landscape for future investigations.

摘要

局部胰腺癌的治疗方法也已经发展为优先采用术前(新辅助)多模式治疗,而不是首选手术治疗。鉴于胰腺癌分期的复杂性和提供多种治疗方式(化疗、放疗和手术)的挑战,需要一个经验丰富且高度整合的多学科团队来实现最佳治疗效果。在这篇综述中,我们将讨论我们机构在新辅助治疗方面的经验、治疗指导原则,并概述未来研究的前景。

相似文献

1
Ten-year experience in optimizing neoadjuvant therapy for localized pancreatic cancer-Medical college of Wisconsin perspective.十年本地化胰腺癌新辅助治疗优化经验——威斯康星医学院观点。
J Surg Oncol. 2021 May;123(6):1405-1413. doi: 10.1002/jso.26395.
2
Neoadjuvant therapy for pancreas cancer: Global perspective and optimal care pathways in low to middle-income countries.胰腺癌的新辅助治疗:中低收入国家的全球视角和最佳护理路径。
J Surg Oncol. 2021 May;123(6):1441-1448. doi: 10.1002/jso.26365.
3
Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma.新辅助治疗用于胰腺导管腺癌的趋势。
J Surg Oncol. 2021 May;123(6):1432-1440. doi: 10.1002/jso.26384.
4
A review of response in neoadjuvant therapy for exocrine pancreatic cancer.胰腺外分泌癌新辅助治疗的疗效综述
J Surg Oncol. 2021 May;123(6):1449-1459. doi: 10.1002/jso.26369.
5
Multidisciplinary management of locally advanced pancreatic adenocarcinoma: Biology is King.局部进展期胰腺腺癌的多学科综合治疗:生物学是关键。
J Surg Oncol. 2021 May;123(6):1395-1404. doi: 10.1002/jso.26415.
6
Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution?胰腺导管腺癌:新辅助治疗变革的时机到了?
Updates Surg. 2020 Jun;72(2):321-324. doi: 10.1007/s13304-020-00798-3.
7
Nowadays pancreatic cancer prognosis.如今胰腺癌的预后情况。
Med Clin (Barc). 2019 May 17;152(10):395-396. doi: 10.1016/j.medcli.2018.12.005. Epub 2019 Feb 2.
8
Combined treatment for locally advanced pancreatic cancer.局部晚期胰腺癌的联合治疗
Lancet Oncol. 2019 Jul;20(7):e351. doi: 10.1016/S1470-2045(19)30381-X. Epub 2019 Jun 6.
9
Resection of Replaced Common Hepatic Artery in Locally Advanced Pancreatic Cancer: A Case Report and Analysis of Technical and Oncological Implications.局部进展期胰腺癌中替代肝总动脉的切除术:一例报告及技术和肿瘤学意义分析
Pancreas. 2020 Apr;49(4):e31-e33. doi: 10.1097/MPA.0000000000001533.
10
The role of neoadjuvant therapy in pancreatic cancer: a review.新辅助治疗在胰腺癌中的作用:综述
Future Oncol. 2016 Mar;12(5):669-85. doi: 10.2217/fon.15.335. Epub 2016 Feb 1.

引用本文的文献

1
Association between systemic immunity-inflammation index and sex hormones in children and adolescents aged 6-19.6-19 岁儿童和青少年全身免疫炎症指数与性激素的关系。
Front Endocrinol (Lausanne). 2024 Jun 13;15:1355738. doi: 10.3389/fendo.2024.1355738. eCollection 2024.